NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept back onto his 5-foot-5-inch frame.
A little over a year ago, the 58-year-old Manhattan resident went on a new weight loss drug called Wegovy. He’s lost 30 pounds, and has started eating healthier food and exercising — the habits behind many commercial diet plans and decades of conventional wisdom on sustainable weight loss.
Yet Jobling’s experience also has altered his perspective on dieting. He now sees obesity as a disease that requires medical intervention, not just behavioral changes. In fact, he thinks he will need to stay on a drug like Wegovy for the rest of his life even though it has taken some of the joy out of eating.
Amtrak train hits pickup truck in upstate New York, 3 dead including child
Leonardo DiCaprio's girlfriend Vittoria Ceretti, 25, oils up for a racy Marc Jacobs campaign
FDIC chair is grilled on Capitol Hill after report outlines agency's toxic workplace culture
Ship that caused Baltimore bridge collapse has been refloated
Alaska lawmakers end their session with late bills passing on energy, education
Preakness is up next for Brian Hernandez after winning the Derby with a perfect trip on Mystik Dan
Rory McIlroy loves life inside the ropes, shoots 66 on first day at PGA
Yu Darvish extends scoreless innings streak to 25 in Padres' 9
National political themes will lead off the campaign for Pennsylvania's next attorney general
Shooting injures 2 at Missouri high school graduation ceremony
Will Smith calls estranged wife Jada Pinkett Smith one of his 'ride